Omega Ophthalmics’ intraocular lens increases the efficacy of cataract surgery and provides a space for in-eye technology, including AR/VR.
Omega Ophthalmics has raised $320K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2026.
Omega Ophthalmics is headquartered in Lexington, United States.
Omega Ophthalmics’ intraocular lens increases the efficacy of cataract surgery and provides a space for in-eye technology, including AR/VR.
Omega Ophthalmics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Omega Ophthalmics — Funding & Investors." VCBacked, January 15, 2026, https://www.vcbacked.co/company/omega-ophthalmics. Accessed August 15, 2026.
VCBacked. (2026). Omega Ophthalmics — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/omega-ophthalmics
{{cite web |title=Omega Ophthalmics — Funding & Investors |url=https://www.vcbacked.co/company/omega-ophthalmics |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated